HCP

Fujifilm’s ASPIRE Cristalle Digital Mammography System Receives Health Canada Medical Device License

Thursday, October 14, 2021 - 4:51pm

Mississauga, Ont., Canada, Oct. 14, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Canada Inc. announced today that the company has received Health Canada medical device license for its ASPIRE Cristalle digital mammography solution and its expansion of the partnership with Christie Innomed to offer the product with superior service in every province across the country.

Key Points: 
  • Mississauga, Ont., Canada, Oct. 14, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Canada Inc. announced today that the company has received Health Canada medical device license for its ASPIRE Cristalle digital mammography solution and its expansion of the partnership with Christie Innomed to offer the product with superior service in every province across the country.
  • ASPIRE Cristalle is featured with Digital Breast Tomosynthesis (DBT) technology, also known as 3D mammography.
  • The ASPIRE Cristalle with DBT combines Fujifilms Hexagonal Close Pattern (HCP) capture technology and intelligent image processing to optimize dose and contrast based on individual breast composition.
  • Fujifilms ASPIRE Cristalle mammography system with DBT is available for purchase and shipping in Canada, beginning on October 1st, 2021.

Deloitte Launches CognitiveSpark™ for Marketing Artificial Intelligence Solution

Thursday, October 14, 2021 - 2:03pm

NEW YORK, Oct. 14, 2021 /PRNewswire/ -- Deloitte today announced the launch of its ConvergeHEALTH CognitiveSpark for Marketing artificial intelligence (AI) precision engagement solution, a module of the CognitiveSpark suite.

Key Points: 
  • NEW YORK, Oct. 14, 2021 /PRNewswire/ -- Deloitte today announced the launch of its ConvergeHEALTH CognitiveSpark for Marketing artificial intelligence (AI) precision engagement solution, a module of the CognitiveSpark suite.
  • CognitiveSpark for Marketing harnesses the power of AI to boost digital marketing ROI for life sciences companies.
  • Life sciences companies face several challenges when using digital marketing approaches to improve patient engagement, including:
    Siloed marketing and sales functions:"Stove pipe" patient marketing, and sales functions contribute to disconnected engagement.
  • The cloud-based solution can integrate within an existing marketing analytics ecosystem to generate knowledge and inform marketing spend across multiple channels.

Fujifilm’s ASPIRE Cristalle Digital Mammography System Receives Health Canada Medical Device License

Thursday, October 14, 2021 - 2:15pm

Mississauga, Ont., Canada, Oct. 14, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Canada Inc. announced today that the company has received Health Canada medical device license for its ASPIRE Cristalle digital mammography solution, and announced its expansion of the partnership with Christie Innomed to offer the product with superior service in every province across the country.

Key Points: 
  • Mississauga, Ont., Canada, Oct. 14, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Canada Inc. announced today that the company has received Health Canada medical device license for its ASPIRE Cristalle digital mammography solution, and announced its expansion of the partnership with Christie Innomed to offer the product with superior service in every province across the country.
  • ASPIRE Cristalle is featured with Digital Breast Tomosynthesis (DBT) technology, also known as 3D mammography.
  • The ASPIRE Cristalle with DBT combines Fujifilms Hexagonal Close Pattern (HCP) capture technology and intelligent image processing to optimize dose and contrast based on individual breast composition.
  • Fujifilms ASPIRE Cristalle mammography system with DBT is available for purchase and shipping in Canada, beginning on October 1st, 2021.

US Physicians Strongly Support COVID-19 Boosters, But Stop Short of Widespread Booster Recommendations, Says New InCrowd Data

Thursday, October 14, 2021 - 1:30pm

Furthermore, physicians estimate that 54% of their patients have already obtained a Pfizer booster (17%) or intend to do so (37%).

Key Points: 
  • Furthermore, physicians estimate that 54% of their patients have already obtained a Pfizer booster (17%) or intend to do so (37%).
  • It would also miss an estimated 28% who are resistant regardless of booster eligibility.
  • As for vaccine mandates in general, 80% strongly support mandatory vaccine initiatives for healthcare workers, as have been enacted or proposed in many states.
  • The InCrowd COVID-19 vaccine booster shot survey reflects data from n=101 US physicians responding on Sunday, October 10, 2021 morning ET in a 90-minute window.

Keen360 Released Keen Life Sciences for Pharma, Biotech & Medical Device Industries to Extend Creatio's No-code Platform Capabilities

Thursday, October 14, 2021 - 1:44pm

The pre-configured application offers enterprise-caliber functionality and security, extending the no-code Creatio platform capabilities to allow professionals engaged in commercial operations in the life sciences industry to power-up their day-to-day operations.

Key Points: 
  • The pre-configured application offers enterprise-caliber functionality and security, extending the no-code Creatio platform capabilities to allow professionals engaged in commercial operations in the life sciences industry to power-up their day-to-day operations.
  • Keen Life Sciences is well suited for both well-established companies that are relying on mature commercial teams and rapidly-growing ventures that areemerging from clinical trials and launching their commercial teams.
  • The solution offers the full range of functionality usually found in the complex and expensiveapplications that are built on the SFDC platform.
  • Key Keen Life Sciences features:
    HCO & HCP profiles:capture and maintain the range of domain-specific information about your HCOs and HCPs.

Hitachi Vantara Outlines Vision for Hybrid Cloud Data Storage at 'The Road Ahead: Digital Infrastructure for the Data-Driven' Event

Tuesday, October 12, 2021 - 4:30pm

SANTA CLARA, Calif., Oct. 12, 2021 /PRNewswire/ -- Hitachi Vantara , the digital infrastructure, data management and analytics, and digital solutions subsidiary of Hitachi Ltd. (TSE: 6501), today shared its vision for the future of hybrid cloud data storage at the event ' The Road Ahead: Digital Infrastructure for the Data-Driven '.

Key Points: 
  • SANTA CLARA, Calif., Oct. 12, 2021 /PRNewswire/ -- Hitachi Vantara , the digital infrastructure, data management and analytics, and digital solutions subsidiary of Hitachi Ltd. (TSE: 6501), today shared its vision for the future of hybrid cloud data storage at the event ' The Road Ahead: Digital Infrastructure for the Data-Driven '.
  • "Today we are excited to announce enhancements to our portfolio that will play a key role in the future of hybrid cloud data strategies," said Mark Ablett, president of Digital Infrastructure at Hitachi Vantara.
  • Hitachi Vantara today introduced new versions of its VSP E590 and E790 storage solutions for small and midsized enterprise clients.
  • Integrations with leading cloud services platforms also help clients lay the foundation for extending data fabrics to the cloud.

Amgen's Aimovig and Eli Lilly's Emgality Feel the Heat From Strong Uptake of Biohaven's Nurtec ODT Among Primary Care Physicians for Migraine Prevention, According to Spherix Global Insights

Tuesday, October 12, 2021 - 12:30pm

However, PCP prescribing patterns appear ready to disrupt, rather than merely expand, CGRP prescribing in migraine prevention.

Key Points: 
  • However, PCP prescribing patterns appear ready to disrupt, rather than merely expand, CGRP prescribing in migraine prevention.
  • While these physicians report a relatively low preventive treatment rate among low-frequency episodic migraine patients, the rate more than doubles among high-frequency episodic migraine patients.
  • In addition, there is a concern that patients may run out of Nurtec ODT doses, given payer restrictions on quantity limits.
  • In addition, both Amgen and Eli Lilly appear to be addressing the Nurtec ODT threat head on.

Boston-based VUE Health announces the launch of Florida-based LATITUDE HEALTH

Tuesday, October 12, 2021 - 11:00am

BOSTON and WEST PALM BEACH, Fla., Oct. 12, 2021 /PRNewswire/ -- VUE Health, a Boston-based pharmaceutical marketing firm, has expanded its offering to include their new sister company, LATITUDE HEALTH, the next generation of cross-cultural pharma marketing.

Key Points: 
  • BOSTON and WEST PALM BEACH, Fla., Oct. 12, 2021 /PRNewswire/ -- VUE Health, a Boston-based pharmaceutical marketing firm, has expanded its offering to include their new sister company, LATITUDE HEALTH, the next generation of cross-cultural pharma marketing.
  • Located in Florida, Latitude was formed to deliver authentic campaigns that resonate with target audiences by combining data and analytics with medical expertise and award-winning creative.
  • According to CEO Kathryn Wilson, "This has been my passion project for quite some time.
  • But if the last 18 months showed us anything, what makes us different might be the biggest uniting factor there is."

Steve Kurzeja Named Chief Revenue Officer of Life Sciences Tech Innovator P360

Wednesday, October 6, 2021 - 2:29pm

P360 , a leading developer of technology for life sciences companies, today announced that veteran pharmaceutical industry executive Steve Kurzeja was appointed the companys first chief revenue officer (CRO).

Key Points: 
  • P360 , a leading developer of technology for life sciences companies, today announced that veteran pharmaceutical industry executive Steve Kurzeja was appointed the companys first chief revenue officer (CRO).
  • View the full release here: https://www.businesswire.com/news/home/20211006005006/en/
    P360 Chief Revenue Officer Steve Kurzeja (Photo: Business Wire)
    Steves vast experience leading revenue-generating initiatives for pharmaceutical companies makes him the perfect fit to serve as chief revenue officer of P360, stated P360 CEO and Founder Anupam Nandwana.
  • I am thrilled to be joining such an innovative and passionate group of industry disruptors, said P360 Chief Revenue Officer Steve Kurzeja.
  • The appointment of Steve Kurzeja as chief revenue officer comes just as P360 announced that its ZING Communication Module has been enhanced with several new enterprise-grade unified communication features.

Aktana Launches Next Generation of its Contextual Intelligence Engine to Accelerate Enterprise-Wide AI Adoption

Wednesday, October 6, 2021 - 12:24pm

SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aktana , the leader in intelligent customer engagement for the global life sciences industry, today announced its Contextual Intelligence Engine (CIE) 2.0.

Key Points: 
  • SAN FRANCISCO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Aktana , the leader in intelligent customer engagement for the global life sciences industry, today announced its Contextual Intelligence Engine (CIE) 2.0.
  • The upgraded version of the CIE is designed specifically for two of the most urgent needs in life sciences commercial operations today: omnichannel optimization and AI flexibility.
  • Contextual Intelligence Engine 2.0 can work with any number of analytical models simultaneously to find the best combination of all possible activities, in all channels, by all members of the commercial team.
  • Today, commercial and medical teams from nearly 300 brands use Aktanas AI-enabled Contextual Intelligence Engine to coordinate and optimize personalized omnichannel engagement at scale.